Evidence map›Paper›PMID 41786844›Full record

ArticleScientific reports2026

Enhanced photocatalytic and antibacterial performance of LaMnCeO

Nastaran Parsafard, Ali Riahi-Madvar

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nastaran ParsafardDepartment of Applied Chemistry, Kosar University of Bojnord, Bojnord, North Khorasan, Iran. n-parsafard@kub.ac.ir.
Ali Riahi-MadvarDepartment of Molecular and Cell Biology, Kosar University of Bojnord, Bojnord, North Khorasan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, LaMnCeO3/TiO2 nanocomposites modified with MXene were synthesized with varying La: Mn: Ce ratios to investigate their photocatalytic performance, charge-transfer behavior, and surface-related characteristics. TEM analysis revealed that MXene forms thin lamellar sheets, serving as a dispersive support for predominantly spherical or semi-spherical LaMnCeO3/TiO2 nanoparticles (sizes ranging from a few nanometers to ~ 100 nm). EDS mapping confirmed uniform distribution of La, Mn, Ce, Ti, O, and C throughout the composites. Structural and spectroscopic analyses demonstrated successful MXene incorporation, formation of mesoporous architectures with tunable surface areas, and compositional control over electronic transitions and chemical bonding. Photocatalytic studies indicated that LMC-112 achieved the highest dye degradation efficiency, while LMC-111 exhibited outstanding stability over five consecutive cycles. The photocatalytic performance was strongly dependent on pH, temperature, dye concentration, and reaction time. EIS, PL, and XPS analyses revealed efficient interfacial charge transfer, suppressed electron–hole recombination, and active surface defect states, which collectively enhanced reactive oxygen species (ROS) generation. Importantly, antibacterial assays revealed negligible microbial inhibition under the tested conditions, indicating that the material does not exhibit strong antibacterial activity. Overall, the LaMnCeO3/TiO2/MXene nanocomposites provide a stable and highly efficient platform for visible-light-driven wastewater treatment and environmental remediation, with performance tunable through compositional and structural optimization.

Indexed as

Anti-Bacterial AgentsAzo CompoundsLanthanumNanocompositesTitaniumCatalysisCeriumLightNitritesOxidesPhotolysisTransition ElementsAnti-Bacterial AgentsAzo CompoundsCeriumLanthanumMXeneNitritesOxidesTitaniumtitanium dioxideTransition ElementsLaMnCeO3/TiO2/MXeneMethyl redPerovskitePhotocatalysisRSM optimizationVisible light

Identifiers

PMID41786844
PMCPMC13079796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.